Advertisement
Screener

Prime Medicine, Inc. (PRME) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Prime Medicine, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Prime Medicine, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $162.56M went out.
  • Fiscal year ended 2025-12-31: from investing, $108.76M went out.
  • Fiscal year ended 2025-12-31: from financing, $151.51M came in.
  • Fiscal year ended 2025-12-31: change in cash, $119.81M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$162.56M-$108.76M$0.00$151.51M*-$119.81M
2024-12-31-$122.86M$68.46M$38.08M$157.79M*$141.47M
2023-12-31-$165.41M$18.71M$0.00$655.00K*-$146.05M
2022-12-31-$131.83M-$47.10M$219.00K$181.28M*$2.57M
2021-12-31-$34.08M-$73.63M$0.00$269.28M*$161.57M
2020-12-31-$5.54M-$1.06M$0.00$34.93M*$28.33M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$41.05M*$24.03M*$23.00K*
2026-03-31-$42.71M$43.39M$393.00K$1.07M
2025-12-31-$37.26M*$28.33M*$0.00*$562.00K*
2025-09-30-$35.04M*-$92.12M*$373.00K*$144.38M*
2025-06-30-$41.41M*$2.77M*$0.00*
2025-03-31-$48.86M-$47.74M$0.00$6.00M*-$90.60M
2024-12-31$16.25M*$48.25M*$0.00*
2024-09-30-$25.91M*$50.34M*$32.00K*$38.48M*
2024-06-30-$45.49M*$6.89M*$35.00K*
2024-03-31-$67.71M-$37.03M$36.00K$157.29M*$52.59M
2023-12-31-$43.86M*$41.28M*$0.00*
2023-09-30-$39.17M*-$37.77M*$318.00K*
2023-06-30-$40.82M*$27.86M*$75.00K*
2023-03-31-$41.56M-$12.66M$68.00K-$54.16M
2022-12-31-$30.71M*-$13.69M*$156.00K*$183.92M*
2022-09-30-$30.10M*-$13.51M*$63.00K*-$746.00K*
2022-06-30-$20.22M*-$50.79M*$0.00*-$624.00K*
2022-03-31-$50.79M$30.89M$0.00-$1.27M*-$21.17M
2021-12-31-$13.19M*$12.15M*$0.00*-$1.09M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B